260.63
price down icon2.43%   -6.50
pre-market  Pre-market:  261.40   0.77   +0.30%
loading
Penumbra Inc stock is traded at $260.63, with a volume of 276.32K. It is down -2.43% in the last 24 hours and down -4.49% over the past month. Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
See More
Previous Close:
$267.13
Open:
$266.93
24h Volume:
276.32K
Relative Volume:
0.64
Market Cap:
$10.04B
Revenue:
$1.16B
Net Income/Loss:
$34.55M
P/E Ratio:
303.06
EPS:
0.86
Net Cash Flow:
$134.18M
1W Performance:
-6.14%
1M Performance:
-4.49%
6M Performance:
+39.42%
1Y Performance:
+11.66%
1-Day Range:
Value
$256.54
$266.93
1-Week Range:
Value
$254.50
$278.81
52-Week Range:
Value
$148.00
$310.00

Penumbra Inc Stock (PEN) Company Profile

Name
Name
Penumbra Inc
Name
Phone
(510) 995-2486
Name
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Name
Employee
4,500
Name
Twitter
@penumbrainc
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
PEN's Discussions on Twitter

Compare PEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
PEN
Penumbra Inc
260.63 10.04B 1.16B 34.55M 134.18M 0.86
Medical Devices icon
ABT
Abbott Laboratories
129.89 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.37 140.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
363.66 138.77B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
92.33 118.39B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
67.95 39.95B 5.72B 4.17B 259.90M 6.97

Penumbra Inc Stock (PEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-21-25 Initiated UBS Buy
Dec-17-24 Initiated Oppenheimer Outperform
Dec-11-24 Upgrade Wells Fargo Equal Weight → Overweight
Sep-18-24 Initiated Stifel Buy
Sep-03-24 Initiated Leerink Partners Outperform
Jul-31-24 Downgrade Citigroup Buy → Neutral
Jul-31-24 Downgrade Wells Fargo Overweight → Equal Weight
Feb-23-24 Downgrade JP Morgan Overweight → Neutral
Sep-06-23 Initiated Morgan Stanley Equal-Weight
Jul-19-23 Initiated Robert W. Baird Outperform
Mar-29-23 Downgrade Needham Buy → Hold
Jan-30-23 Initiated Piper Sandler Overweight
Nov-04-22 Upgrade Citigroup Neutral → Buy
Oct-12-22 Initiated Jefferies Buy
Oct-05-22 Downgrade Citigroup Buy → Neutral
Sep-09-22 Upgrade Needham Hold → Buy
Jul-18-22 Initiated RBC Capital Mkts Outperform
Apr-19-22 Initiated Deutsche Bank Buy
Mar-08-22 Initiated Needham Hold
Sep-16-21 Initiated Truist Buy
Jun-04-21 Upgrade BTIG Research Neutral → Buy
Dec-16-20 Downgrade BTIG Research Buy → Neutral
Oct-07-20 Resumed Canaccord Genuity Buy
Sep-29-20 Initiated BTIG Research Buy
Sep-08-20 Downgrade BofA Securities Buy → Neutral
Mar-05-20 Initiated Citigroup Buy
Jun-13-19 Reiterated BofA/Merrill Buy
May-30-19 Upgrade JP Morgan Neutral → Overweight
May-21-19 Initiated William Blair Outperform
Oct-29-18 Resumed BofA/Merrill Buy
Oct-08-18 Initiated RBC Capital Mkts Outperform
Feb-21-18 Initiated William Blair Outperform
Jan-02-18 Downgrade JP Morgan Overweight → Neutral
Nov-30-15 Reiterated Canaccord Genuity Buy
Oct-13-15 Initiated Wells Fargo Outperform
View All

Penumbra Inc Stock (PEN) Latest News

pulisher
Mar 13, 2025

Penumbra, Inc. (NYSE:PEN) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Penumbra Off And Running On Renewed Enthusiasm For Mechanical Thrombectomy - Seeking Alpha

Mar 12, 2025
pulisher
Mar 09, 2025

Adam Elsesser Sells 61,600 Shares of Penumbra, Inc. (NYSE:PEN) Stock - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Penumbra CEO Adam Elsesser sells $17.47 million in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Penumbra CEO Adam Elsesser sells $17.47 million in stock - Investing.com

Mar 07, 2025
pulisher
Mar 06, 2025

Penumbra director O’Rourke sells $14,274 in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Penumbra director Arani sells $3.45 million in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Penumbra’s Growth Potential Balanced by Market Uncertainties: A Hold Recommendation - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Penumbra, Inc. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 05, 2025

Insider Sell: Arani Bose Sells 12,000 Shares of Penumbra Inc (PE - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Insider Sell: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra director O’Rourke sells $14,274 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra EVP Johanna Roberts sells shares worth $172,458 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra EVP Johanna Roberts sells shares worth $172,458 By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra’s chief accounting officer sells shares worth over $2.2 million - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra CFO Maggie Yuen sells $571,994 in stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra director Arani sells $3.45 million in stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra Announces Board Transition with Kassing’s Retirement - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

Aspiration-first approaches gather further traction thanks to ‘game-changing’ thrombectomy technologies - NeuroNews International

Mar 04, 2025
pulisher
Mar 03, 2025

Penumbra Inc.: Will Its Market Penetration & Access Initiatives Help Capture The Thrombectomy Market? - Smartkarma

Mar 03, 2025
pulisher
Mar 01, 2025

Los Angeles Capital Management LLC Raises Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Penumbra Investor Alert: Shareholder Lawsuit Filed - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Growing Thrombectomy Business Supports PEN Stock, Macro Issues Ail - MSN

Feb 28, 2025
pulisher
Feb 27, 2025

Acute Pulmonary Embolism Treatment Market Size in the 7MM - openPR

Feb 27, 2025
pulisher
Feb 25, 2025

Q1 Earnings Estimate for Penumbra Issued By Leerink Partnrs - MarketBeat

Feb 25, 2025
pulisher
Feb 24, 2025

Penumbra Inc. Faces Financial Peril Amid Rising Customer Payment Defaults - TipRanks

Feb 24, 2025
pulisher
Feb 24, 2025

Penumbra (NYSE:PEN) Stock Rating Upgraded by StockNews.com - MarketBeat

Feb 24, 2025
pulisher
Feb 24, 2025

Robert W. Baird Boosts Penumbra (NYSE:PEN) Price Target to $328.00 - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

Penumbra (PEN) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 23, 2025
pulisher
Feb 23, 2025

Penumbra (NYSE:PEN) Releases Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 23, 2025
pulisher
Feb 22, 2025

Penumbra (PEN) Upgraded to Buy: Here's Why - MSN

Feb 22, 2025
pulisher
Feb 22, 2025

Piper Sandler Reiterates Overweight Rating for Penumbra (NYSE:PEN) - MarketBeat

Feb 22, 2025
pulisher
Feb 22, 2025

Penumbra, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance

Feb 22, 2025
pulisher
Feb 22, 2025

Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion - MSN

Feb 22, 2025
pulisher
Feb 22, 2025

Penumbra price target raised to $320 from $305 at UBS - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

Penumbra Announces Don Kassing Will Retire From Board Of Directors -February 21, 2025 at 05:50 pm EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors - PR Newswire

Feb 21, 2025
pulisher
Feb 21, 2025

Neuro-interventional Devices Market Growth in Future Scope - openPR

Feb 21, 2025
pulisher
Feb 20, 2025

Why Penumbra (PEN) Stock Is Trading Up Today - MSN

Feb 20, 2025
pulisher
Feb 19, 2025

Penumbra Inc. Earnings Call Reveals Strong U.S. Growth - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

Here's What Key Metrics Tell Us About Penumbra (PEN) Q4 Earnings - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook - Benzinga India

Feb 19, 2025

Penumbra Inc Stock (PEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$107.57
price up icon 3.40%
medical_devices STE
$222.45
price down icon 0.89%
medical_devices PHG
$26.11
price down icon 2.03%
$68.48
price down icon 3.22%
$81.45
price down icon 2.79%
medical_devices EW
$67.95
price down icon 0.82%
Cap:     |  Volume (24h):